Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UCB | Brussels | Healthcare | Pharmaceuticals | €31.32B | 29.4x | 0.14 | €164.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.9% Upside | Upgrade to Pro+ | |
Argen-X | Brussels | Healthcare | Biotechnology & Medical Research | €30.92B | 32.9x | 0.09 | €506.40 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.8% Upside | Upgrade to Pro+ | |
Tubize-Fin | Brussels | Healthcare | Pharmaceuticals | €5.79B | 64.5x | 28.99 | €130 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.6% Upside | Upgrade to Pro+ | |
Fagron | Brussels | Healthcare | Pharmaceuticals | €1.60B | 20x | 1.43 | €21.95 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.1% Upside | Upgrade to Pro+ | |
Ion Beam Applications | Brussels | Healthcare | Healthcare Equipment & Supplies | €364.08M | 38.2x | 0.2 | €12.44 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.6% Upside | Upgrade to Pro+ | |
Nyxoah | Brussels | Healthcare | Healthcare Equipment & Supplies | €255.63M | -3.5x | 0.11 | €6.83 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ONWARD Medical BV | Brussels | Healthcare | Healthcare Equipment & Supplies | €190.64M | -5.1x | -0.16 | €4.27 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyloris | Brussels | Healthcare | Pharmaceuticals | €168M | -25.2x | -0.46 | €6 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AGFA Gevaert | Brussels | Healthcare | Healthcare Equipment & Supplies | €161.01M | -1.6x | 0.03 | €1.04 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.1% Upside | Upgrade to Pro+ | |
Sequana Medical | Brussels | Healthcare | Biotechnology & Medical Research | €57.32M | -0.8x | -13.51 | €1 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biocartis Group NV | Brussels | Healthcare | Healthcare Equipment & Supplies | €27.24M | -0.3x | €0.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
European Medical Solutions | Brussels | Healthcare | Healthcare Providers & Services | €18.41M | 37.6x | 0.19 | €4.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celyad | Brussels | Healthcare | Biotechnology & Medical Research | €17.23M | -3.6x | -0.05 | €0.42 | 7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biosenic | Brussels | Healthcare | Pharmaceuticals | €1.44M | -0x | -0 | €0.002 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oxurion | Brussels | Healthcare | Biotechnology & Medical Research | €378.94K | 1x | 0.03 | €0.04 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Personalized Nursing Services | Brussels | Healthcare | Healthcare Providers & Services | €245K | €0.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |